therapeutic multiepitope vaccine (LT-fused, melanoma) (Dan Immunotherapy)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nametherapeutic multiepitope vaccine (LT-fused, melanoma) (Dan Immunotherapy)
Drug Alias NameMEP-mel
ClassificationBiologics > Antigen > Tumor antigenBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Toxin +[5
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDan Immunotherapy Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDan Immunotherapy Ltd
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A